{"transactions":[{"id":2157621,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"officer":true,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-16T20:15:53.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":81250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met."}],"balance_after":81250,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":81250},"source":{"system":"sec-edgar","filing":"0001140361-22-033613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122033613/form4.xml","form_type":"4"}},{"id":2425458,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T01:42:21.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":100000,"derivative":{"exercise_price":2.42,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-22-001778","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761922001778/doc1.xml","form_type":"4"}},{"id":2425457,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Common Stock","published_at":"2022-01-27T01:42:21.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2022, with the first annual vest occurring on February 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,685 shares acquired under the Issuer's stock purchase plan."}],"balance_after":60260,"source":{"system":"sec-edgar","filing":"0001567619-22-001778","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761922001778/doc1.xml","form_type":"4"}},{"id":2523325,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T23:04:11.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":81250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted a performance-based option to purchase 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On November 4, 2021, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested on October 25, 2021, the date the performance metric had been met."}],"balance_after":81250,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":81250},"source":{"system":"sec-edgar","filing":"0001567619-21-019429","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000156761921019429/doc1.xml","form_type":"4"}},{"id":2762077,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T22:24:15.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on February 6, 2020. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On April 1, 2021, it was determined that the performance metric had been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested on April 1, 2021, the date the performance metric had been met."}],"balance_after":37500,"derivative":{"exercise_price":2.42,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001179110-21-004128","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021004128/edgar.xml","form_type":"4"}},{"id":2890668,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option(right to buy)","published_at":"2021-01-29T23:51:22.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2021, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":125000,"derivative":{"exercise_price":3.54,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-21-000983","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021000983/edgar.xml","form_type":"4"}},{"id":3284934,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T23:30:21.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":150000,"derivative":{"exercise_price":2.42,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-20-001350","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911020001350/edgar.xml","form_type":"4"}},{"id":3364577,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-21T01:11:34.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted a performance based option to purchase 75,000 shares of common stock on January 24, 2018. Thus,the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met."}],"balance_after":75000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-19-011940","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019011940/edgar.xml","form_type":"4"}},{"id":3581875,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-22T23:22:01.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met."}],"balance_after":75000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-19-004207","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019004207/edgar.xml","form_type":"4"}},{"id":3686934,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T23:20:52.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019."}],"balance_after":162500,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001179110-19-000932","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019000932/edgar.xml","form_type":"4"}},{"id":3937327,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-11T23:41:02.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 2, 2017 the reporting person was granted an option to purchase 150,000 shares of common stock.  The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved.  On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option."}],"balance_after":150000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-18-006679","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018006679/edgar.xml","form_type":"4"}},{"id":4088430,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-26T23:27:25.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018."}],"balance_after":150000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-18-001141","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018001141/edgar.xml","form_type":"4"}},{"id":4347883,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T21:55:05.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 26, 2016 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option."}],"balance_after":150000,"derivative":{"exercise_price":2.74,"expiration_date":"2026-01-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-006154","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017006154/edgar.xml","form_type":"4"}},{"id":4347882,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T21:55:05.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 27, 2014 the reporting person was granted an option to purchase 125,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 62,500 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 62,500 shares of common stock, resulting in full vesting of the option."}],"balance_after":62500,"derivative":{"exercise_price":3.59,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-17-006154","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017006154/edgar.xml","form_type":"4"}},{"id":4466613,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":123743,"kind":"person","name":"VANCE DOLLY","position":1,"cik":"0001237676","reported_name":"VANCE DOLLY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Corp. Affairs, G.C., Sect."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T00:23:45.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over four (4) years from January 1, 2017."}],"balance_after":150000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-001816","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017001816/edgar.xml","form_type":"4"}}]}